The once-daily beta-agonist was better than placebo and at least as good as twice-daily salmeterol, as measured by the SGRQ, TDI, and FEV1 after 12 weeks.
Once-daily indacaterol as effective as salmeterol bid for COPD
Once-daily indacaterol as effective as…
Once-daily indacaterol as effective as salmeterol bid for COPD
The once-daily beta-agonist was better than placebo and at least as good as twice-daily salmeterol, as measured by the SGRQ, TDI, and FEV1 after 12 weeks.